Elamipretide (SS-31) Peptide: Mitochondrial Protection and Therapeutic Potential
A cutting-edge mitochondria-targeted peptide antioxidant for enhanced cellular health and disease management.
Get a Quote & SampleProduct Core Value
SS-31 Peptide Lyophilized Powder
Elamipretide (SS-31) is a potent, mitochondria-targeted tetrapeptide renowned for its ability to protect cellular energy production and combat oxidative stress. Its unique mechanism involves binding to cardiolipin within the inner mitochondrial membrane, thereby stabilizing mitochondrial structure and function. This action leads to enhanced ATP synthesis, reduced reactive oxygen species (ROS) generation, and protection against mitochondrial dysfunction, which is a hallmark of many chronic and age-related diseases.
- Explore the benefits of SS-31 peptide mitochondrial protection for cellular vitality and energy management.
- Discover the therapeutic potential of Elamipretide for neurodegenerative diseases, offering neuroprotection and improving synaptic plasticity.
- Understand how SS-31 peptide enhances ATP production, a critical factor for sustained cellular energy and function.
- Learn about the application of SS-31 in treating mitochondrial dysfunction, a key contributor to various chronic health conditions.
Key Advantages of SS-31 Peptide
Enhanced Mitochondrial Function
SS-31 actively protects mitochondrial membranes, preserving their integrity and optimizing the electron transport chain for improved ATP synthesis, directly combating mitochondrial dysfunction.
Potent Antioxidant Activity
The peptide effectively scavenges reactive oxygen species (ROS), mitigating oxidative damage at the cellular level and protecting against the deleterious effects of free radicals.
Broad Therapeutic Potential
Research indicates SS-31's efficacy across a spectrum of conditions, including cardiovascular diseases, neurological disorders, and age-related ailments, showcasing its versatility.
Key Applications
Cardiovascular Health
Elamipretide is investigated for its role in improving cardiac function and reducing injury in conditions like heart failure and myocardial infarction, leveraging its cardioprotective effects.
Neurological Disorders
Its ability to cross the blood-brain barrier and protect neurons makes SS-31 a promising candidate for treating Alzheimer's disease, Parkinson's disease, and other neurodegenerative conditions.
Age-Related Diseases
By targeting mitochondrial aging processes, SS-31 shows potential in addressing age-associated decline in tissue function and the progression of age-related diseases.
Genetic Mitochondrial Diseases
Studies suggest SS-31's benefit in specific genetic disorders like Friedreich's Ataxia and Barth Syndrome, where it aids in improving mitochondrial quality and function.
Related Technical Articles & Resources
Why Choose Us?
Leverage our expertise and state-of-the-art infrastructure to accelerate your journey from discovery to commercial success.
Global Experience
With 20 years of R&D, manufacturing, and sales experience, we proudly serve clients across 60 countries and regions worldwide.
Advanced Facilities
Our in-house R&D laboratory, pilot platform, and large-scale production workshop are equipped to meet the audit requirements of global customers.
Seamless Scalability
We facilitate a perfect transition from small-scale lab requirements (grams) to full commercialization (hundreds of tons).